Annual Shareholders Equity
$442.02 M
+$46.96 M+11.89%
December 31, 2023
Summary
- As of February 22, 2025, VRDN annual stockholders equity is $442.02 million, with the most recent change of +$46.96 million (+11.89%) on December 31, 2023.
- During the last 3 years, VRDN annual shareholders equity has risen by +$321.99 million (+268.24%).
- VRDN annual shareholders equity is now at all-time high.
Performance
VRDN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$707.50 M
+$178.16 M+33.66%
September 30, 2024
Summary
- As of February 22, 2025, VRDN quarterly stockholders equity is $707.50 million, with the most recent change of +$178.16 million (+33.66%) on September 30, 2024.
- Over the past year, VRDN quarterly shareholders equity has increased by +$423.92 million (+149.49%).
- VRDN quarterly shareholders equity is now at all-time high.
Performance
VRDN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VRDN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.9% | +149.5% |
| 3 y3 years | +268.2% | +149.5% |
| 5 y5 years | +760.9% | +149.5% |
VRDN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +135.5% | at high | +398.6% |
| 5 y | 5-year | at high | +2705.8% | at high | +4390.9% |
| alltime | all time | at high | +1950.5% | at high | +3061.8% |
Viridian Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $707.50 M(+33.7%) |
| Jun 2024 | - | $529.34 M(-9.1%) |
| Mar 2024 | - | $582.53 M(+31.8%) |
| Dec 2023 | $442.02 M(+11.9%) | $442.02 M(+55.9%) |
| Sep 2023 | - | $283.58 M(-10.2%) |
| Jun 2023 | - | $315.86 M(-9.9%) |
| Mar 2023 | - | $350.55 M(-11.3%) |
| Dec 2022 | $395.06 M(+110.5%) | $395.06 M(-3.4%) |
| Sep 2022 | - | $409.01 M(+188.2%) |
| Jun 2022 | - | $141.90 M(-14.8%) |
| Mar 2022 | - | $166.64 M(-11.2%) |
| Dec 2021 | $187.72 M(+56.4%) | $187.72 M(-8.2%) |
| Sep 2021 | - | $204.59 M(+106.8%) |
| Jun 2021 | - | $98.91 M(-6.7%) |
| Mar 2021 | - | $106.00 M(-11.7%) |
| Dec 2020 | $120.04 M(+661.9%) | $120.04 M(+470.5%) |
| Sep 2020 | - | $21.04 M(-0.6%) |
| Jun 2020 | - | $21.17 M(-21.6%) |
| Mar 2020 | - | $27.00 M(+71.4%) |
| Dec 2019 | $15.75 M | $15.75 M(-32.0%) |
| Sep 2019 | - | $23.17 M(-30.7%) |
| Jun 2019 | - | $33.44 M(-18.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $40.96 M(-20.2%) |
| Dec 2018 | $51.34 M(+33.3%) | $51.34 M(-15.4%) |
| Sep 2018 | - | $60.72 M(-10.3%) |
| Jun 2018 | - | $67.67 M(-6.9%) |
| Mar 2018 | - | $72.71 M(+88.8%) |
| Dec 2017 | $38.51 M(<-9900.0%) | $38.51 M(-1.2%) |
| Sep 2017 | - | $38.98 M(-5.7%) |
| Jun 2017 | - | $41.34 M(-13.9%) |
| Mar 2017 | - | $47.99 M(<-9900.0%) |
| Dec 2016 | -$326.00 K(-103.1%) | -$326.00 K(-107.0%) |
| Sep 2016 | - | $4.69 M(-27.2%) |
| Jun 2016 | - | $6.44 M(-22.8%) |
| Mar 2016 | - | $8.34 M(-19.9%) |
| Dec 2015 | $10.41 M(+73.8%) | $10.41 M(-17.6%) |
| Sep 2015 | - | $12.63 M(+15.4%) |
| Jun 2015 | - | $10.94 M(-16.8%) |
| Mar 2015 | - | $13.15 M(+119.5%) |
| Dec 2014 | $5.99 M(-125.1%) | $5.99 M(-20.4%) |
| Sep 2014 | - | $7.53 M(-11.0%) |
| Jun 2014 | - | $8.46 M(+420.7%) |
| Mar 2014 | - | $1.63 M(-106.8%) |
| Dec 2013 | -$23.89 M(+11.4%) | -$23.89 M |
| Dec 2012 | -$21.44 M | - |
FAQ
- What is Viridian Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Viridian Therapeutics?
- What is Viridian Therapeutics annual shareholders equity year-on-year change?
- What is Viridian Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly shareholders equity year-on-year change?
What is Viridian Therapeutics annual stockholders equity?
The current annual shareholders equity of VRDN is $442.02 M
What is the all time high annual shareholders equity for Viridian Therapeutics?
Viridian Therapeutics all-time high annual stockholders equity is $442.02 M
What is Viridian Therapeutics annual shareholders equity year-on-year change?
Over the past year, VRDN annual stockholders equity has changed by +$46.96 M (+11.89%)
What is Viridian Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VRDN is $707.50 M
What is the all time high quarterly shareholders equity for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly stockholders equity is $707.50 M
What is Viridian Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VRDN quarterly stockholders equity has changed by +$423.92 M (+149.49%)